Novel 1‐(1‐benzyl‐2‐oxoindolin‐3‐ylidene)thiosemicarbazides (6a–l) bearing a 3‐sulfamoylphenyl moiety selectively inhibited the tumor‐associated hCA IX and XII isoforms over hCA I and II isoforms at the nanomolar levels. Compounds 6k and 6f emerged as the most potent inhibitors of hCA IX and XII, respectively.
Çağla Begüm Apaydın +3 more
wiley +1 more source
Computational and Experimental Characterization of <i>Mycobacterium marinum</i> β-Carbonic Anhydrase Inhibitors. [PDF]
Morshed N +3 more
europepmc +1 more source
Hypotony following the use of topical carbonic anhydrase inhibitors in glaucoma patients: a case report and review of literature. [PDF]
AlTariqi SM, Halawani MA, AlOtaiby ND.
europepmc +1 more source
Click Chemistry-Enabled Parallel Synthesis of <i>N</i>-Acyl Sulfonamides and Their Evaluation as Carbonic Anhydrase Inhibitors. [PDF]
Gavrylenko OV +14 more
europepmc +1 more source
A simple mathematical approach to identifying baseline predictors of the effectiveness of carbonic anhydrase inhibitors in intraocular pressure reduction. [PDF]
Dendumrongsup W.
europepmc +1 more source
Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors. [PDF]
Kumar P +11 more
europepmc +1 more source
Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma. [PDF]
Tucker-Retter EK +3 more
europepmc +1 more source
Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis. [PDF]
Wey S, Brill DA, Miraldi Utz V, Sisk RA.
europepmc +1 more source
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitors. [PDF]
Eissa IH +10 more
europepmc +1 more source

